The Impact of a Hematopoietic Cellular Therapy Pharmacist on Clinical and Humanistic Outcomes: A RE-AIM Framework Analysis-Reference-Cited by-同舟云学术

The Impact of a Hematopoietic Cellular Therapy Pharmacist on Clinical and Humanistic Outcomes: A RE-AIM Framework Analysis

Published:2022-06 Issue:6 Volume:28 Page:334.e1-334.e9
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Andrick Benjamin^ORCID,Tusing Lorraine,Jones Laney K.^ORCID,Hu Yirui,Sneidman Rachel,Gregor Christina,Basu Soumit,Lynch Joseph P.,Vadakara Joseph^ORCID

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference27 articles.

1. Phelan R, Arora M, Chen M. Current uses and outcomes of hematopoietic cell transplantation (HCT): CIBMTR Summary Slides. Available at: https://www.cibmtr.org. Accessed December 1st, 2021.

2. The Hematopoietic cell transplant pharmacist: roles, responsibilities, and recommendations from the ASBMT Pharmacy Special Interest Group;Clemmons;Biol Blood Marrow Transplant,2018

3. Consensus recommendations for the role and competencies of the EBMT clinical pharmacist and clinical pharmacologist involved in hematopoietic stem cell transplantation;Langebrake;Bone Marrow Transplant,2020

4. National Survey of Hematopoietic Cell Transplantation Center Personnel, Infrastructure, and Models of Care Delivery;Majhail;Biol Blood Marrow Transplant,2015

5. Oncology pharmacists can reduce the projected shortfall in cancer patient visits: projections for years 2020 to 2025;Knapp;Pharmacy (Basel),2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multidisciplinary Care and ICU Organization for Hematopoietic Stem Cell Transplantation Patients;Pulmonary and Critical Care Considerations of Hematopoietic Stem Cell Transplantation;2023